Study guide
9.3 Returning & Reusing Drugs (Rule 6800.2700)
Minnesota MPJE Pharmacy Jurisprudence
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the Minnesota MPJE 1.2 NABP Competency Areas & Weights 1.3 How to Use This Guide & Study Strategy
2 Federal Controlled Substances Foundations
2.1 CSA Schedules I–V & MN Alignment 2.2 DEA Registration, Forms 222/106/41 & Security 2.3 Federal CS Prescription Rules (CII–CV) 2.4 Inventories, Recordkeeping & Theft/Loss
3 Federal Drug Regulation, Privacy & Supply Chain
3.1 FD&C Act, Legend vs OTC, Misbranding & Adulteration 3.2 OBRA '90, Medicaid DUR & Federal Counseling Floor 3.3 HIPAA Privacy for Pharmacy 3.4 DSCSA & Drug Supply Chain Integrity
4 MN Board, Licensure & Eligibility
4.1 Minnesota Board of Pharmacy Authority & Sources of Law 4.2 Pharmacist Licensure by Exam & Score Transfer 4.3 License Transfer (Reciprocity) & Background Checks 4.4 Interns, Preceptors & 1,600-Hour Experience
5 Renewal, CE, PIC & Discipline
5.1 License Renewal & 30-Hour Biennial CE 5.2 Pharmacist-in-Charge Duties 5.3 Discipline & Unprofessional Conduct 5.4 HPSP, Impaired Practitioners & Mandatory Reporting
6 Technicians, Interns & Supervision
6.1 Technician Registration, Training & CE 6.2 Supervision Ratios (Statute 151.102 & Rule 6800.3850) 6.3 Intern Scope, Delegation & Certification of Accuracy
7 Prescription Authority & Validity
7.1 Who May Prescribe in Minnesota 7.2 Prescription Content & Validity Requirements 7.3 Controlled Substance Prescribing (Chapter 152 + Federal) 7.4 Refills, Partial Fills & Quantity Limits
8 Advanced MN Pharmacist Practice
8.1 Collaborative Practice Agreements & Medication Therapy Management 8.2 Pharmacist Prescriptive Authority (Minn. Stat. 151.37) 8.3 Immunizations & Vaccine Administration 8.4 Drug Administration & Therapy Management
9 Counseling, DUR & Patient Safety
9.1 Patient Counseling Requirements (Rule 6800.0910) 9.2 Prospective Drug Utilization Review 9.3 Returning & Reusing Drugs (Rule 6800.2700)
10 MN PMP & Opioid Public-Health Laws
10.1 Minnesota PMP Overview, Reporting & Pharmacist Use 10.2 Naloxone Access, Steve’s Law & Opioid Antagonists 10.3 Legitimate Medical Purpose & Red Flags
11 Dispensing: Transfers, Labels & Substitution
11.1 Prescription Transfers Between Pharmacies 11.2 Labeling & Packaging of Dispensed Drugs 11.3 Generic Substitution & Product Selection 11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine
12 Pharmacy Operations & Facilities
12.1 Pharmacy Permits, Classifications & Inspections 12.2 Security, Delivery & Work Conditions 12.3 Operational Recordkeeping & Inventories 12.4 Central Fill, Centralized Processing & Automation
13 Compounding & Hazardous Drugs
13.1 Sterile, Nonsterile & Hazardous Compounding 13.2 Minnesota Compounding Rules & Beyond-Use Dates
14 Test-Day Strategy & Final Review
14.1 When Minnesota Law Is Stricter Than Federal Law 14.2 Test-Day Strategy & Common Traps
9.3 Returning & Reusing Drugs (Rule 6800.2700)
Key Takeaways Explain This Topic AI
Rule 6800.2700 generally prohibits pharmacists and pharmacies from accepting drugs, prescribed medications, chemicals, poisons, or medical devices from patients or their agents for reuse, reissue, or resale.
Hospital inpatient exception: items dispensed for hospital inpatient use only that have not left the pharmacy’s span of control may return for reuse or disposal consistent with good professional practice.
Nursing-home and assisted-living returns may be redispensed only when all rule conditions are met, including USP-proper secure storage, 24-hour on-site licensed nursing seven days a week, return to the same dispensing pharmacy, intact packaging, and compliant unit packaging.
Reconstituted drugs, drugs requiring refrigeration, and controlled substances may not be returned for redispensing under the nursing-home/ALF pathway.
Commingling returned medication or mixing lot numbers upon or prior to repackaging renders the medication misbranded and subject to embargo under Minn. Stat. §151.38; devices have a separate sanitary-reuse path.
Last updated: July 2026
9.3 Returning & Reusing Drugs (Rule 6800.2700)
Quick Answer: Rule 6800.2700 generally prohibits pharmacists and pharmacies from accepting from patients or their agents for reuse, reissue, or resale any drugs, prescribed medications, chemicals, poisons, or medical devices. Limited exceptions exist for hospital inpatient items that never left pharmacy span of control , and for nursing home/assisted living returns that meet all integrity, storage, nursing-coverage, same-pharmacy, and packaging conditions— no reconstituted, refrigerated, or controlled substances on that redispensing path. Commingling returned lots is misbranding subject to embargo under Minn. Stat. §151.38 .
Returning-and-reusing questions test patient safety and drug integrity , not generosity. The default Minnesota answer is almost always: do not put a patient’s returned bottle back into active inventory for another patient. Exceptions are narrow, cumulative, and integrity-driven . Do not invent extra exceptions (donation programs, “sealed blister from Grandma’s purse,” or “CS unit-dose always OK”) unless a rule you can cite actually allows them.
General Prohibition (Subpart 1) — Start Here on Every Stem
Pharmacists and pharmacies are prohibited from accepting from patients or their agents for reuse, reissue, or resale any:
- Drugs
- Prescribed medications
- Chemicals
- Poisons
- Medical devices
This is the community-pharmacy baseline . A patient returning unused amoxicillin after a dental procedure does not create restock inventory—even if the bottle “looks sealed,” the patient “stored it carefully,” or the drug is “expensive.” Outside a qualifying exception, the safe legal posture is refuse for redispensing (disposal pathways and take-back programs are separate public-health topics; they are not a free license to restock retail inventory).
Hospital inpatient exception (same subpart)
In a hospital with a licensed pharmacy , drugs, devices, or other items dispensed for hospital inpatient use only that have not left the span of control of the pharmacy may be returned to the pharmacy for reuse or disposal in accordance with good professional practice .
Key teaching points:
- Concept Exam meaning
- Hospital with licensed pharmacy Institutional setting with pharmacy control, not a random clinic closet
- Inpatient use only Not ordinary outpatient community prescriptions
- Not left span of control Continuous institutional custody; not “patient took it home and brought it back”
- Reuse or disposal Pharmacist judgment under professional practice standards
If the drug left pharmacy control into a patient’s personal possession outside that inpatient span-of-control model, you are back in the general prohibition .
Nursing Homes and Assisted Living Facilities (Subpart 2)
Drugs from nursing homes and assisted living facilities may be returned to the dispensing pharmacy . Returned drugs may be redispensed only if all of the following are satisfied:
A. Storage integrity assured by consultant pharmacist
The consultant pharmacist can assure proper storage conditions in the facility as specified in the USP , and the drugs are stored within the facility in a secure area .
B. Continuous licensed nursing coverage
The facility has 24-hour, on-site licensed nursing coverage seven days a week .
C. Same pharmacy
The drugs are returned to the same pharmacy that dispensed them.
D. Packaging integrity + hard exclusions
The integrity of packaging remains intact . Critically, the rule states that no reconstituted drugs, drugs requiring refrigeration, or controlled substances may be so returned (for redispensing under this pathway).
E. Packaging form and labeling
Drugs must be received in:
The original manufacturer’s packaging , or
Pharmacist packager’s unit-dose, unit-of-use, or strip packaging with each tablet or capsule individually wrapped and labeled, or in blister cards , indicating drug name and strength , the packager’s name , and the manufacturer’s or packager’s lot or batch number
If the pharmacy packaged the product, the pharmacy must be able to demonstrate to the Board that packaging materials and procedures meet or exceed USP Class B packaging criteria and that procedures prevent commingling of dosage units of different lot numbers or beyond-use dates .
Teach the “all conditions” discipline
MPJE items often omit one element—no 24-hour nursing, different pharmacy, CS blister card, refrigerated insulin pens, reconstituted antibiotic suspension. Missing any required element means redispensing is not authorized under this exception. Do not “almost” the rule.
Commingling and Misbranding (Subpart 3)
Commingling of returned medication or mixing of lot numbers of returned medication, upon or prior to repackaging, shall result in such medication being deemed misbranded and subject to embargo under Minnesota Statutes section 151.38 .
This prohibition does not apply to return of medical devices provided proper sanitary procedures are used prior to reuse, resale, or re-rent. Devices and oral solids are not interchangeable logic on the exam.
How to Reason a Return/Reuse Vignette
Use this decision tree:
Is someone asking to restock a patient-returned drug for reuse/resale? Start with prohibited .
Hospital inpatient + never left pharmacy span of control? Possible reuse/disposal under professional practice.
Nursing home/ALF return for redispensing? Check A–E all true , and exclude CS / refrigerated / reconstituted .
Would repackaging mix lots? Stop— misbranded / embargo risk .
Device rather than drug? Apply sanitary-procedure device language, not oral-drug restock myths.
Integration with Counseling and DUR
Counseling (6800.0910) and DUR (6800.3110) protect patients before the first dose leaves with incomplete understanding or an unsafe regimen.
Returns (6800.2700) protect the next patient from unknown storage, contamination, diversion, and lot/BUD chaos.
Area 2 blueprint language expressly includes returning/reusing drugs —expect scenario items, not only statute number matching.
Study Checklist
State the general prohibition without hedging.
Define the hospital span-of-control exception carefully.
List all five NH/ALF redispensing conditions and the CS/refrigerated/reconstituted ban .
Connect commingling to misbranding and §151.38 embargo .
Refuse to invent “sealed bottle from home” exceptions that the rule does not grant.